Viewing Study NCT00604266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:28 PM
Ignite Modification Date: 2026-01-31 @ 2:58 AM
Study NCT ID: NCT00604266
Status: WITHDRAWN
Last Update Posted: 2017-05-04
First Post: 2008-01-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Sponsor: University of Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Potentially resectable hilar cholangiocarcinoma as per initial imaging studies. View
None Able to undergo PET/CT and MRI with Gadolinium View